Intrauterine Balloon Dilatation Therapy in the Prevention of Adhesion Formation After Hysteroscopic Myomectomy

Launched by FU XING HOSPITAL, CAPITAL MEDICAL UNIVERSITY · May 25, 2017

Keywords

ClinConnect Summary

Objectives

To investigate the efficacy of intrauterine balloon (IUB) dilatation therapy in the prevention of adhesion formation after transcervical resection of submucous myomas (TCRM).

Patients

The patients will be recruited from two centers, namely, the Hysterscopy Center of the Fuxing Hospital and TianTan Hospital, Capital Medical University, Beijing, China. Before the surgery all patients with suspected submucous myomas will undergo preoperative evaluations including trans-vaginal ultrasonography. The inclusion criteria include \[1\] women aged 18-45 years with regular 25-35 days cyc...

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • \[1\] women aged 18-45 years with regular 25-35 days cycles ;
• • \[2\] no evidence of intrauterine adhesions at the time of surgery;
• • \[3\] written consent obtained;
• • \[4\] agreement to have second-look hysteroscopy;
• • \[5\] had more than one fibroids removed at the time of hysteroscopic surgery
• Exclusion Criteria:
• • \[1\] women who are already postmenopausal
• • \[2\] women who have evidence of intrauterine adhesions at the time of surgeryare